Evron Evyatar, Juhasz Margit, Babadjouni Arash, Mesinkovska Natasha Atanaskova
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Department of Dermatology, University of California, Irvine, Irvine, California, USA.
Skin Appendage Disord. 2020 Nov;6(6):329-337. doi: 10.1159/000509905. Epub 2020 Aug 23.
Saw palmetto (SP), a botanical extract with antiandrogenic properties, has gained commercial popularity for its purported benefits on hair regrowth. To summarize published evidence on the efficacy, safety, and tolerability of supplements containing SP in the treatment of alopecia, we conducted a PubMed, Google Scholar, and Cochrane database search using the following terms: (saw palmetto and hair loss), (saw palmetto and androgenetic alopecia), and (saw palmetto and natural supplement and alopecia). Five randomized clinical trials (RCTs) and 2 prospective cohort studies demonstrated positive effects of topical and oral supplements containing SP (100-320 mg) among patients with androgenetic alopecia (AGA) and telogen effluvium. Sixty percent improvement in overall hair quality, 27% improvement in total haircount, increased hair density in 83.3% of patients, and stabilized disease progression among 52% were noted with use of various topical and oral SP-containing supplements. SP was well tolerated and not associated with serious adverse events in alopecia patients. Although robust high-quality data are lacking, supplements containing SP may be a treatment option for patients with AGA, telogen effluvium, and self-perceived hair thinning. Further large-scale RCTs focusing on the sole contribution of SP to hair growth outcomes are needed to confirm efficacy and determine long-term adverse events.
锯棕榈(SP)是一种具有抗雄激素特性的植物提取物,因其据称对头发生长的益处而在商业上颇受欢迎。为了总结已发表的关于含锯棕榈补充剂治疗脱发的疗效、安全性和耐受性的证据,我们使用以下术语在PubMed、谷歌学术和Cochrane数据库中进行了搜索:(锯棕榈和脱发)、(锯棕榈和雄激素性脱发)以及(锯棕榈和天然补充剂和脱发)。五项随机临床试验(RCT)和两项前瞻性队列研究表明,含锯棕榈(100 - 320毫克)的局部和口服补充剂对雄激素性脱发(AGA)和休止期脱发患者有积极作用。使用各种含锯棕榈的局部和口服补充剂后,总体头发质量改善了60%,总头发数量增加了27%,83.3%的患者头发密度增加,52%的患者疾病进展得到稳定。锯棕榈耐受性良好,在脱发患者中未发现与严重不良事件相关。尽管缺乏有力的高质量数据,但含锯棕榈的补充剂可能是AGA、休止期脱发和自我感觉头发稀疏患者的一种治疗选择。需要进一步开展大规模的RCT,重点关注锯棕榈对头发生长结果的单独作用,以确认疗效并确定长期不良事件。